Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study for the Treatment of Children and Adolescents With Newly Diagnosed Low Risk Hodgkin Disease

NCT00302003 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00302003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00302003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study for the Treatment of Children and Adolescents With Newly Diagnosed Low Risk Hodgkin Disease
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2006
Completion date
June 30, 2019
Enrollment
287 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood favorable prognosis hodgkin lymphoma, childhood lymphocyte depletion hodgkin lymphoma, childhood mixed cellularity hodgkin lymphoma, childhood nodular sclerosis hodgkin lymphoma, stage i childhood hodgkin lymphoma, stage ii childhood hodgkin lymphoma